Overview

Psilocybin Therapy for Depression in Parkinson's Disease

Status:
RECRUITING
Trial end date:
2028-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to understand whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy.
Phase:
PHASE2
Details
Lead Sponsor:
Joshua Woolley, MD, PhD
Treatments:
Psilocybin